Publications by authors named "Rebecca Ansell"
Rheumatology (Oxford)
April 2022
Article Synopsis
- The study explored how some patients with axial spondyloarthritis (axSpA) experience subjective symptom deterioration before their scheduled doses of three different TNF inhibitors (TNFis): etanercept, adalimumab, and infliximab.
- By analyzing MRI scans and clinical assessments, it was found that many patients showed high disease activity and a notable presence of bone marrow edema (MRI-BMO) before their doses.
- The results indicated that shorter periods between doses correlated with fewer new lesions and improved clinical responses, but further research is necessary to understand the implications of these findings.
